FROVATRIPTAN BIOGARAN 2.5 mg, film-coated tablet 12 tablets
Active ingredients: Frovatriptan, Frovatriptan succinate hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FROVATRIPTAN BIOGARAN 2,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène polychlortrifluoroéthylène aluminium de 12 comprimé(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65235238CIP73016064CIP133400930160640Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FROVATRIPTANcomprimé | 2,50 mg · un comprimé | FT |
| SUCCINATE DE FROVATRIPTAN MONOHYDRATÉcomprimé | 3,91 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.